AACR Award for Outstanding Achievement in Chemistry in Cancer Research

Funding Agency:
American Association for Cancer Research

The AACR and its Chemistry in Cancer Research Working Group established this Award in 2007, through the support of GlaxoSmithKline, to recognize the importance of chemistry to advancements in cancer research.

The Award is intended to recognize outstanding, novel, and significant chemistry research, which has led to important contributions in basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. Such research may include, but is not limited to, chemical aspects of carcinogenesis; chemical biology; drug discovery and design; imaging agents and radiotherapeutics; metabolomics and mass spectrometry; proteomics; and structural biology.

Deadline for nominations: July 31, 2020

Agency Website

Eligibility Requirements


  • Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.

  • The Award will be presented to an individual investigator. Two or more individuals may be selected to share the Award in the event that their investigations are closely related in subject matter and have resulted in work worthy of an award.

  • Institutions and/or organizations are not eligible to receive the Award.

  • Prior recipients of the AACR Bruce F. Cain Memorial Award are not eligible to be nominated for research previously recognized by the AACR Bruce F. Cain Memorial Award.



Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

July 31, 2020